Dealing with missing outcome data in meta‐analysis

Missing data result in less precise and possibly biased effect estimates in single studies. Bias arising from studies with incomplete outcome data is naturally propagated in a meta‐analysis. Conventional analysis using only individuals with available data is adequate when the meta‐analyst can be confident that the data are missing at random (MAR) in every study—that is, that the probability of missing data does not depend on unobserved variables, conditional on observed variables. Usually, such confidence is unjustified as participants may drop out due to lack of improvement or adverse effects. The MAR assumption cannot be tested, and a sensitivity analysis to assess how robust results are to reasonable deviations from the MAR assumption is important. Two methods may be used based on plausible alternative assumptions about the missing data. Firstly, the distribution of reasons for missing data may be used to impute the missing values. Secondly, the analyst may specify the magnitude and uncertainty of possible departures from the missing at random assumption, and these may be used to correct bias and reweight the studies. This is achieved by employing a pattern mixture model and describing how the outcome in the missing participants is related to the outcome in the completers. Ideally, this relationship is informed using expert opinion. The methods are illustrated in two examples with binary and continuous outcomes. We provide recommendations on what trial investigators and systematic reviewers should do to minimize the problem of missing outcome data in meta‐analysis.

[1]  Ian R White,et al.  Analyses of Sensitivity to the Missing-at-Random Assumption Using Multiple Imputation With Delta Adjustment: Application to a Tuberculosis/HIV Prevalence Survey With Incomplete HIV-Status Data , 2017, American journal of epidemiology.

[2]  Dimitris Mavridis,et al.  Allowing for Informative Missingness in Aggregate Data Meta-Analysis with Continuous or Binary Outcomes: Extensions to Metamiss , 2018, The Stata journal.

[3]  Dimitris Mavridis,et al.  Addressing missing outcome data in meta-analysis , 2014, Evidence-Based Mental Health.

[4]  J. Higgins Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration , 2011 .

[5]  A. E. Ades,et al.  A Bayesian framework to account for uncertainty due to missing binary outcome data in pairwise meta‐analysis , 2015, Statistics in medicine.

[6]  John M Davis,et al.  Is the superior efficacy of new generation antipsychotics an artifact of LOCF? , 2006, Schizophrenia bulletin.

[7]  Stephen Rollnick,et al.  Lassa fever: epidemiology, clinical features, and social consequences , 2004, BMJ : British Medical Journal.

[8]  Geert Molenberghs,et al.  Sensitivity analysis for incomplete categorical data , 2001 .

[9]  N. Pandis,et al.  Reporting and handling missing outcome data in mental health: a systematic review of Cochrane systematic reviews and meta‐analyses , 2015, Research synthesis methods.

[10]  Douglas G. Altman,et al.  Special Topics in Statistics , 2008 .

[11]  R. White Ian,et al.  Sensitivity Analysis: The Elicitation and Use of Expert Opinion , 2014 .

[12]  J. Ioannidis,et al.  Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis , 2018, The Lancet.

[13]  Julian Pt Higgins,et al.  Evaluating the impact of imputations for missing participant outcome data in a network meta-analysis , 2013, Clinical trials.

[14]  Dimitris Mavridis,et al.  Allowing for uncertainty due to missing and LOCF imputed outcomes in meta‐analysis , 2018, Statistics in medicine.

[15]  Dimitris Mavridis,et al.  Allowing for uncertainty due to missing continuous outcome data in pairwise and network meta‐analysis , 2015, Statistics in medicine.

[16]  Patrick Royston,et al.  Multiple imputation using chained equations: Issues and guidance for practice , 2011, Statistics in medicine.

[17]  Lara A Kahale,et al.  Reporting missing participant data in randomised trials: systematic survey of the methodological literature and a proposed guide , 2015, BMJ Open.

[18]  G. Antes,et al.  CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials , 2011 .

[19]  I. White,et al.  Eliciting and using expert opinions about dropout bias in randomized controlled trials , 2007, Clinical trials.

[20]  David Moher,et al.  Evaluation of the Cochrane Collaboration’s tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation , 2014, Systematic Reviews.

[21]  Michael G. Kenward,et al.  Missing Data in Clinical Trials - A Practical Guide , 2007 .

[22]  Michele Tarsilla Cochrane Handbook for Systematic Reviews of Interventions , 2010, Journal of MultiDisciplinary Evaluation.

[23]  I. White,et al.  Meta-analysis with Missing Data , 2009 .

[24]  Xin Sun,et al.  Addressing continuous data for participants excluded from trial analysis: a guide for systematic reviewers. , 2013, Journal of clinical epidemiology.

[25]  Ian R White,et al.  Allowing for uncertainty due to missing data in meta‐analysis—Part 1: Two‐stage methods , 2008, Statistics in medicine.

[26]  Nicky J Welton,et al.  Allowing for uncertainty due to missing data in meta‐analysis—Part 2: Hierarchical models , 2008, Statistics in medicine.

[27]  Melanie L Bell,et al.  Handling missing data in RCTs; a review of the top medical journals , 2014, BMC Medical Research Methodology.

[28]  Douglas G Altman,et al.  Epidemiology and reporting of randomised trials published in PubMed journals , 2005, The Lancet.

[29]  David B. Allison,et al.  Missing Data in Randomized Clinical Trials for Weight Loss: Scope of the Problem, State of the Field, and Performance of Statistical Methods , 2009, PloS one.

[30]  Ian R White,et al.  Imputation methods for missing outcome data in meta-analysis of clinical trials , 2008, Clinical trials.

[31]  S. Hollis,et al.  What is meant by intention to treat analysis? Survey of published randomised controlled trials , 1999, BMJ.

[32]  Nicole A. Lazar,et al.  Statistical Analysis With Missing Data , 2003, Technometrics.

[33]  M. Kenward,et al.  Handbook of Missing Data Methodology , 2019 .

[34]  David C. Currow,et al.  Quality of missing data reporting and handling in palliative care trials demonstrates that further development of the CONSORT statement is required: a systematic review , 2017, Journal of clinical epidemiology.

[35]  M. Kenward,et al.  Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls , 2009, BMJ : British Medical Journal.

[36]  R. Little,et al.  The prevention and treatment of missing data in clinical trials. , 2012, The New England journal of medicine.

[37]  D. Altman,et al.  Assessing Risk of Bias in Included Studies , 2008 .

[38]  Clive E Adams,et al.  Haloperidol versus placebo for schizophrenia. , 2013, The Cochrane database of systematic reviews.

[39]  Ian R White,et al.  Strategy for intention to treat analysis in randomised trials with missing outcome data , 2011, BMJ : British Medical Journal.

[40]  Carrol Gamble,et al.  Uncertainty method improved on best-worst case analysis in a binary meta-analysis. , 2005, Journal of clinical epidemiology.

[41]  D. Moher,et al.  CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials , 2010, Journal of pharmacology & pharmacotherapeutics.